Entrar Registro gratuito

ProMIS Neurosciences Quick ratio

Qual é o Quick ratio de ProMIS Neurosciences?

O Quick ratio de ProMIS Neurosciences, Inc. é 18.34

Qual é a definição de Quick ratio?



Liquidez Reduzida é o indicador de liquidez que mede a capacidade de uma empresa de usar seus ativos rápidos para cumprir suas obrigações de curto prazo imediatamente.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio de empresas na Setor Health Care em OTC em comparação com ProMIS Neurosciences

O que ProMIS Neurosciences faz?

ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

Empresas com quick ratio semelhantes a ProMIS Neurosciences